T3 Companies’s Revelation Biosciences Warrant REVBW Stock Holding History

T3 Companies’s Portfolio REVBW Stock Details REVBW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.45K	Hold	198,090	–	–	﹤0.01%	184
2026 Q2	$1.56K	Hold	198,090	–	–	﹤0.01%	171
2026 Q1	$0	Hold	198,090	–	–	﹤0.01%	232
2025 Q4	$1.58K	Buy	+198,090	New	+$2.14K	﹤0.01%	187

Other funds holding REVBW

Quaker Wealth Management Moorestown, New Jersey $341M AUM 9.06% 1-Year Est. Return

T3 Companies's REVBW Position: Q3 2026 in Review

T3 Companies held its Revelation Biosciences Warrant (REVBW) position steady in Q3 2026 at 198,090 shares worth $1.45K. The position accounts for ﹤0.01% of the portfolio, ranked #184.

T3 Companies first reported a position in REVBW in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.58K in Q4 2025. 2 funds tracked by Wall St. Rank hold REVBW as of Q3 2026.

T3 Companies held 198,090 shares of Revelation Biosciences Warrant worth $1.45K as of Q3 2026.
T3 Companies left its Revelation Biosciences Warrant share count unchanged in Q3 2026.
Revelation Biosciences Warrant made up ﹤0.01% of T3 Companies's portfolio in Q3 2026, its #184 holding.
T3 Companies first reported a position in Revelation Biosciences Warrant in Q4 2025 and has held it in 4 quarters since.
T3 Companies's Revelation Biosciences Warrant position peaked at $1.58K in Q4 2025.
2 funds tracked by Wall St. Rank held Revelation Biosciences Warrant as of Q3 2026.

Based on T3 Companies's 13F filing for Q3 2026, filed 22 Oct 2026.